Analysis and design of randomised clinical trials involving competing risks endpoints
10.1186/1745-6215-12-127
Saved in:
Main Authors: | Tai, B.-C., Wee, J., Machin, D. |
---|---|
Other Authors: | EPIDEMIOLOGY & PUBLIC HEALTH |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/109176 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Defining surrogate endpoints for clinical trials in severe falciparum malaria
by: Atthanee Jeeyapant, et al.
Published: (2018) -
On the Use of Surrogate Endpoints in Randomized Trials (with Discussion)
by: Begg, C. B., et al.
Published: (2000) -
On the Importance of Accounting for Competing Risks in Pediatric Cancer Trials Designed to Delay or Avoid Radiotherapy: I. Basic Concepts and First Analyses
by: Tai, B.-C., et al.
Published: (2011) -
Statistical considerations in the design and analysis of non-inferiority trials with binary endpoints in the presence of non-adherence: A simulation study
by: Mo, Y., et al.
Published: (2021) -
Evaluating primary endpoints for COVID-19 therapeutic trials to assess recovery
by: Douin, David J., et al.
Published: (2023)